Gilead's Kite Pays $135M for Ex-Agensys R&D Building Post author:Sam Post published:January 22, 2018 Post category:BioPharma The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County. Source: BioSpace You Might Also Like AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017 Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention September 24, 2017 <b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men September 26, 2017
AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017
Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention September 24, 2017
<b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men September 26, 2017